Forlivesi, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 561
EU - Europa 494
AS - Asia 309
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 1.369
Nazione #
US - Stati Uniti d'America 558
CN - Cina 244
GB - Regno Unito 136
SE - Svezia 70
SG - Singapore 49
IE - Irlanda 46
IT - Italia 46
RU - Federazione Russa 44
FR - Francia 40
DE - Germania 37
FI - Finlandia 26
UA - Ucraina 13
AT - Austria 11
BE - Belgio 7
KR - Corea 5
JP - Giappone 3
NL - Olanda 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
RS - Serbia 2
TR - Turchia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IN - India 1
IR - Iran 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.369
Città #
Chandler 156
Southend 124
Jacksonville 48
Dublin 46
Ashburn 43
Singapore 41
Woodbridge 40
New York 32
Beijing 31
Nanjing 24
Jinan 21
Shenyang 21
Lawrence 19
Princeton 19
Helsinki 17
Ann Arbor 16
Houston 14
Zhengzhou 13
Tianjin 12
Hebei 11
Vienna 11
Wilmington 10
Changsha 9
Lancaster 9
Nanchang 8
Hangzhou 7
Ningbo 7
Verona 7
Los Angeles 6
Brussels 5
Fuzhou 5
Guangzhou 5
Haikou 5
Jiaxing 5
Boardman 4
Clearwater 4
Dearborn 4
Seoul 4
Taiyuan 4
Esslingen am Neckar 3
Lanzhou 3
Lisbon 3
Munich 3
Saint Louis 3
Schio 3
Taizhou 3
Washington 3
Belgrade 2
Dubai 2
Düsseldorf 2
Milan 2
Modena 2
Redwood City 2
Santa Clara 2
Seattle 2
Sindelfingen 2
Tokyo 2
Waanrode 2
Ahome 1
Athens 1
Baku 1
Bologna 1
Bratislava 1
Budapest 1
Cambridge 1
Conegliano 1
Dallas 1
Edinburgh 1
Fairfield 1
Gangnam-gu 1
Harker Heights 1
Jeffries 1
Kemerovo 1
Las Vegas 1
Ludwigshafen am Rhein 1
Luxembourg 1
Madrid 1
Moscow 1
Mumbai 1
Nave 1
Nicosia 1
Perugia 1
Phoenix 1
Prague 1
Puxian 1
Quito 1
Redmond 1
San Francisco 1
San José 1
Shanghai 1
Sofia 1
Stockholm 1
Tallinn 1
Warsaw 1
Xiangfen 1
Totale 950
Nome #
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 98
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 94
Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke Unit 88
Introduction of direct oral anticoagulant within 7 days of stroke onset: a nomogram to predict the probability of 3-month modified Rankin Scale score > 2 88
Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis 84
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 83
Association of short- and medium-term particulate matter exposure with risk of mortality after spontaneous intracerebral hemorrhage 81
Missing data on 3-month modified Rankin Scale may influence results of functional outcome after intravenous thrombolysis in observational studies 79
Association between short- and medium-term air pollution exposure and risk of mortality after intravenous thrombolysis for stroke 79
Cerebral large-vessel vasculitis as an unusual manifestation of POEMS syndrome 78
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke 74
STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke 73
A nomogram to predict the probability of mortality after first-ever acute manifestations of cerebral small vessel disease 70
Number of ischemic strokes potentially eligible for revascularization treatments in an Italian Comprehensive Stroke Center: a modeling study 61
Mechanical Thrombectomy for Acute Ischemic Stroke in a Patient with Concomitant Spontaneous Intracerebral Hemorrhage 59
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 59
Early secondary prevention after initially ineffective revascularization treatments for acute ischemic stroke due to tandem occlusion 55
Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update 51
Obesity paradox and stroke: a narrative review 47
Totale 1.401
Categoria #
all - tutte 5.333
article - articoli 5.333
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.666


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020108 0 0 0 0 20 22 11 2 29 1 7 16
2020/2021143 35 29 8 26 16 15 0 1 0 0 13 0
2021/2022157 20 60 5 11 4 0 0 9 1 1 12 34
2022/2023404 22 57 27 81 34 82 0 30 42 5 20 4
2023/2024182 4 18 8 31 27 37 2 12 0 15 22 6
2024/2025145 13 29 22 66 15 0 0 0 0 0 0 0
Totale 1.401